InvestorsHub Logo
Followers 74
Posts 15845
Boards Moderated 0
Alias Born 04/26/2010

Re: Atom0aks post# 230588

Wednesday, 11/27/2019 3:02:15 PM

Wednesday, November 27, 2019 3:02:15 PM

Post# of 426475
Yeah, I got two of the CP's mixed up because of that Woodcock letter to the USPTO saying it was too late to file a '146 patent CP, then yesterday the FDA formally denied the CP - both communications were about the same patent, but apparently meant different things - maybe that the USPTO could not accept a CP against that patent if one was filed?

Found a good source of CP's trying to figure this all out - link is to an xlsx file containing all CPs filed from 2007 to current, one worksheet for each year

www.fdalawblog.net › wp-content › uploads › CPTracker

Shows these two are both open - 1st one it claiming EE-EPA is a DS or should be classified as one, 2nd one is the MO CP:

FDA-2019-P-3266 Medical Research Collaborative LLC Carboxylic-acid

FDA-2019-P-3424 Medical Research Collaborative, LLC VASCEPA (icosapent ethyl)

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News